Tabauac, Leny M.
HRN: 22-28-04 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2022
CEFUROXIME 1.5GM (VIAL)
11/30/2022
12/02/2022
IVT
1.5g
Q8
S/P CS
Waiting Final Action